Collaboration of the NIH and PHS Commissioned Corps in the.
Information and resources from the National Center for Complementary and Integrative Health, U.S. National Institutes of Health (NIH). The mission of NCCIH is to define, through rigorous scientific investigation, the usefulness and safety of complementary and integrative health interventions and their roles in improving health and health care.
To address these requirements and the global need for an effective therapy against Ebola virus disease, the Vaccine Research Center (VRC) at the US National Institute of Allergy and Infectious Diseases (NIAID) and US National Institutes of Health (NIH) developed the fully human monoclonal antibody mAb114. mAb114 was identified from a survivor of the 1995 EBOV outbreak in Kikwit, Democratic.
NIH research funding trends are particularly important since this body funds more than 300,000 research scientists and have supported 149 Nobel Laureates since 1939. Federal support of NIH has enabled the development of vaccines for Hepatitis A and Ebola, raised the prostate cancer five-year survival rate to 99%, and resulted in promising advances in the fight against antibiotic resistance.
The Genetic and Rare Diseases Information Center (GARD) is a program of the National Center for Advancing Translational Sciences (NCATS) and is funded by two parts of the National Institutes of Health (NIH): NCATS and the National Human Genome Research Institute (NHGRI). GARD provides the public with access to current, reliable, and easy-to-understand information about rare or genetic diseases.
The NIH Clinical Center does not endorse, authorize or guarantee the sponsors, information, products or services described or offered at this external site. You will be subject to the destination site's privacy policy if you follow this link.
The Clinical Center was recently announced as the first federal medical facility to be recognized by a leading health care organization for eliminating the use of paper charts and maintaining a superior electronic medical record system for inpatient care. Health Information and Management Systems Society (HIMSS) Analytics awarded the research hospital Stage 7 certification, the highest level.
News release by Scripps Research on the latest research paper on HCV vaccine co-sponsored by NIH and Ufovax. April 15, 2020. The new approach to vaccine design may also prove useful in developing a potential vaccine against the SARS-CoV-2 virus, which causes COVID-19. LA JOLLA, CA—A new design for a vaccine against hepatitis C virus (HCV) has shown promise in early tests, according to a.